| Yu, Bo |
NCT04624854: Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD) |
|
|
| Active, not recruiting | 4 | 8250 | RoW | Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin monotherapy | Harbin Medical University, Chinese Society of Cardiology, Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome, Heart Diseases, Syndrome Heart Disease, Cardiovascular Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Coronary Disease, Vascular Diseases | 04/25 | 04/25 | | |
| Active, not recruiting | N/A | 2059 | RoW | Promus PREMIERTM Everolimus-Eluting Platinum Chromium Coronary Stent System | Boston Scientific Corporation | Coronary Artery Disease | 12/20 | 02/25 | | |
| Recruiting | N/A | 4500 | RoW | | Harbin Medical University, Abbott | Acute Myocardial Infarction | 07/21 | 12/22 | | |
| Active, not recruiting | N/A | 347 | RoW | dual antiplatelet therapy (aspirin + ticagrelor or aspirin + clopidogrel) | Harbin Medical University, Shenzhen Salubris Pharmaceuticals Co., Ltd., Beijing Luhe Hospital, The First Hospital of Jilin University, China-Japan Union Hospital, Jilin University, The First Affiliated Hospital of Dalian Medical University, Shanxi Cardiovascular Hospital, Second Hospital of Shanxi Medical University, Hebei General Hospital, General Hospital of Ningxia Medical University, Sichuan Provincial People's Hospital, Affiliated Hospital of Jiangsu University, Xiamen Cardiovascular Hospital, Xiamen University, Shenzhen Sun Yat-sen Cardiovascular Hospital, LanZhou University, Sir Run Run Shaw Hospital, Wuhan Asia Heart Hospital | ST-segment Elevation Myocardial Infarction | 02/22 | 03/23 | | |
EMPOWER, NCT04289480: Safety and Effectiveness of ENTERPRISE 2 Device in the Endovascular Treatment of Intracranial Aneurysms |
|
|
| Active, not recruiting | N/A | 164 | RoW | ENTERPRISE 2 device | Medos International SARL, Johnson & Johnson Medical (Shanghai) Ltd. | Intracranial Aneurysm | 04/22 | 01/27 | | |
NCT05015699: A Study to Evaluate the Impact of 11-month Ticagrelor Monotherapy Following One-month DAPT After PCI |
|
|
| Withdrawn | N/A | 285 | NA | HT Supreme | Sino Medical Sciences Technology Inc., The Second Affiliated Hospital of Harbin Medical University | Coronary Artery Disease | 09/22 | 07/25 | | |
COOPERATION, NCT04912518: Cardioprotective Effect of Dexmedetomidine in Patients With ST-segment Elevation Myocardial Infarction |
|
|
| Recruiting | N/A | 250 | RoW | Dexmedetomidine (DEX), Placebo (Saline) | Harbin Medical University, Yangtze River Pharmaceutical Group Co., Ltd. | ST-segment Elevation Myocardial Infarction (STEMI), Percutaneous Coronary Intervention, Cardioprotection | 12/24 | 12/25 | | |
NCT05818098: Coronary Intravascular Lithotripsy System in Patients With Coronary Artery Calcification (VIGOUR) |
|
|
| Recruiting | N/A | 189 | RoW | Intravascular Lithotripsy System of Shanghai MicroPort Rhythm | Shanghai MicroPort Rhythm MedTech Co., Ltd. | Coronary Artery Calcification | 09/23 | 03/24 | | |
NCT05795829: Ultrasound Ablation for Essential Hypertension（FIM） |
|
|
| Recruiting | N/A | 10 | RoW | disposable intravascular ultrasound ablation catheter and ultrasound ablation instrument | Lepu Medical Technology (Beijing) Co., Ltd. | Uncontrolled Essential Hypertension | 12/23 | 02/24 | | |
NCT06365502: Preventive Drug-coated Balloon Angioplasty in Vulnerable Atherosclerotic Plaque (RESTORE Trial) |
|
|
| Recruiting | N/A | 1860 | RoW | Drug-coated balloon, Guideline-directed medical treatment | Harbin Medical University, Shanghai Shenqi Medical Technology Co., Ltd | Acute Coronary Syndrome (ACS) | 12/27 | 12/30 | | |
| Recruiting | N/A | 180 | RoW | Drug-coated balloon, Guideline-directed medical treatment | Harbin Medical University, Shanghai Shenqi Medical Technology Co., Ltd | Acute Coronary Syndrome (ACS) | 06/26 | 06/26 | | |
NCT06101888: Safety and Effectiveness of TaurusTrio™ Heart Valve System in Patients With Severe Aortic Regurgitation (AR) |
|
|
| Recruiting | N/A | 116 | RoW | TaurusTrio™ Heart Valve System | Peijia Medical Technology (Suzhou) Co., Ltd. | Aortic Regurgitation | 07/24 | 07/29 | | |
NCT04995159: Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVasâ„¢ BRS System |
|
|
| Not yet recruiting | N/A | 2150 | RoW | Single anti-platelet therapy, SAPT strategy, Dual anti-platelet therapy, DAPT strategy | Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Heart Disease | 01/26 | 01/28 | | |
| Zhang, Liming |
| No trials found |
